临床试验/NCT06063746

NCT06063746No Longer Available不适用

Compassionate Use of Vidutolimod

Regeneron Pharmaceuticals0 个研究点开始时间: 2023年10月3日最近更新: 2026年1月8日

相关药物

试验速览

阶段: 不适用
状态: No Longer Available
发起方: Regeneron Pharmaceuticals

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

Provide Compassionate Use of Vidutolimob

详细描述

Compassionate use is only available to patients who transitioned from a previous vidutolimod (CMP-001) study.

研究设计

研究类型: Expanded Access

入排标准

性别: All
接受健康志愿者: 否

入选标准

未提供

排除标准

未提供

研究者

发起方

Regeneron Pharmaceuticals

申办方类型

Industry

责任方

Sponsor

相似试验

Compassionate Use or Expanded Access of Dupilumab

NCT04776694Regeneron Pharmaceuticals

Compassionate Use of Pozelimab

NCT05232110Regeneron Pharmaceuticals

Compassionate Use of EvinacumabPediatric Homozygous Familial Hypercholesterolemia (HoFH)Severe Hypertriglyceridemia (HTG)Dysbetalipoproteinemia (DBL)

NCT06500598Regeneron Pharmaceuticals

No Longer Available

Defibrotide Compassionate Use for Patients With Life Threatening Veno-Occlusive Disease of the LiverLiver Diseases

NCT00263978Emory University

No Longer Available

Casodex 150-mg Compassionate Use Trial for Subjects With Prostate CancerAdenocarcinoma of the Prostate

NCT00636259AstraZeneca